Search

everythinglearnresearchcommunity

for

Search:↓

Severe alopecia areata in South Korea has a high treatment burden, with most patients needing multiple treatments and frequent doctor visits.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

SIG-1451 could be a promising new treatment for atopic dermatitis.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Dermoscopy is effective in diagnosing facial actinic keratosis using specific features.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Minoxidil helps hair regrowth by affecting hair follicles and blood vessels.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Non-obese women with hair loss have higher heart disease risk.

Better diagnostic and treatment strategies are needed for acne keloidalis nuchae, especially in high-risk groups.

Congenital atrichia with papular lesions causes permanent hair loss in children.

New genetic discoveries may lead to better treatments for alopecia areata.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Inflammatory diets may increase the risk and severity of alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Men with Kennedy disease have less chance of hair loss.